Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
To find HDAC8-selective inhibitors, we designed a library of HDAC inhibitor candidates, each containing a zinc-binding group that coordinates with the active-site zinc ion, linked via a triazole moiety to a capping structure that interacts with residues on the rim of the active site. These compounds were synthesized by using click chemistry. Screening identified HDAC8-selective inhibitors including C149 (IC(50) = 0.070 μM), which was more potent than PCI-34058 (6) (IC(50) = 0.31 μM), a known HDAC8 inhibitor. Molecular modeling suggested that the phenylthiomethyl group of C149 binds to a unique hydrophobic pocket of HDAC8, and the orientation of the phenylthiomethyl and hydroxamate moieties (fixed by the triazole moiety) is important for the potency and selectivity. The inhibitors caused selective acetylation of cohesin in cells and exerted growth-inhibitory effects on T-cell lymphoma and neuroblastoma cells (GI(50) = 3-80 μM). These findings suggest that HDAC8-selective inhibitors have potential as anticancer agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These two aromatic hydroxamate derivatives show high selectivity for human HDAC8 (hHDAC8)”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [18]
Citations
Cites
Tornøe, C. W., Christensen, C., & Meldal, M. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo011148j · Cited by 8,696
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Yoshida, M., Horinouchi, S., & Beppu, T. (1995) · BioEssays · doi:10.1002/bies.950170510 · Cited by 713
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678
Vannini, A., Volpari, C., Filocamo, G., Casavola, E. C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404603101 · Cited by 638
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577
Self-citation
Research works printed but not linked: 2
- Yoshida M., 2003, Prog. Cell Cycle Res., 5, 269
- Nakagawa M., 2007, Oncol. Rep., 18, 769
Cited by
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
Zheng, Y.-C., Duan, Y.-C., Ma, J.-L., Xu, R.-M., Zi, X., Lv, W.-L., Wang, M.-M., Ye, X.-W., Zhu, S., Mobley, D., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401002r · Cited by 218
Inhibitors of histone deacetylase as antitumor agents: A critical review
Manal, M., Chandrasekar, M. J. N., Gomathi Priya, J., & Nanjan, M. J. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.05.005 · Cited by 216
Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries
Wang, X., Huang, B., Liu, X., & Zhan, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.08.004 · Cited by 190
Overview of Recent Strategic Advances in Medicinal Chemistry
Wu, G., Zhao, T., Kang, D., Zhang, J., Song, Y., Namasivayam, V., Kongsted, J., Pannecouque, C., De Clercq, E., Poongavanam, V., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00359 · Cited by 181
Next-generation of selective histone deacetylase inhibitors
Yang, F., Zhao, N., Ge, D., & Chen, Y. (2019) · RSC Advances · doi:10.1039/c9ra02985k · Cited by 155
Halogen-atom and group transfer reactivity enabled by hydrogen tunneling
Constantin, T., Górski, B., Tilby, M. J., Chelli, S., Juliá, F., Llaveria, J., Gillen, K. J., Zipse, H., Lakhdar, S., & Leonori, D. (2022) · Science · doi:10.1126/science.abq8663 · Cited by 136
Zhang, L., Han, Y., Jiang, Q., Wang, C., Chen, X., Li, X., Xu, F., Jiang, Y., Wang, Q., & Xu, W. (2015) · Medicinal Research Reviews · doi:10.1002/med.21320 · Cited by 125
Heimburg, T., Chakrabarti, A., Lancelot, J., Marek, M., Melesina, J., Hauser, A.-T., Shaik, T. B., Duclaud, S., Robaa, D., Erdmann, F., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01478 · Cited by 124
Marek, M., Shaik, T. B., Heimburg, T., Chakrabarti, A., Lancelot, J., Ramos-Morales, E., Da Veiga, C., Kalinin, D., Melesina, J., Robaa, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01087 · Cited by 122
Self-citationThe application of histone deacetylases inhibitors in glioblastoma
Chen, R., Zhang, M., Zhou, Y., Guo, W., Yi, M., Zhang, Z., Ding, Y., & Wang, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01643-6 · Cited by 133
Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment
Peng, X., Sun, Z., Kuang, P., & Chen, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112831 · Cited by 121
Strategies To Design Selective Histone Deacetylase Inhibitors
Melesina, J., Simoben, C. V., Praetorius, L., Bülbül, E. F., Robaa, D., & Sippl, W. (2021) · ChemMedChem · doi:10.1002/cmdc.202000934 · Cited by 118
Rodrigues, D. A., Ferreira-Silva, G. À., Ferreira, A. C. S., Fernandes, R. A., Kwee, J. K., Sant’Anna, C. M. R., Ionta, M., & Fraga, C. A. M. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01525 · Cited by 109
Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
Banerjee, S., Adhikari, N., Amin, S. A., & Jha, T. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.039 · Cited by 108
Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases
Chakrabarti, A., Melesina, J., Kolbinger, F. R., Oehme, I., Senger, J., Witt, O., Sippl, W., & Jung, M. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0117 · Cited by 111
Lanka, G., Begum, D., Banerjee, S., Adhikari, N., Yogeeswari, P., & Ghosh, B. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107481 · Cited by 112
Suzuki, T., Kasuya, Y., Itoh, Y., Ota, Y., Zhan, P., Asamitsu, K., Nakagawa, H., Okamoto, T., & Miyata, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068669 · Cited by 101
Self-citationMechanistic applications of click chemistry for pharmaceutical drug discovery and drug delivery
Meghani, N. M., Amin, H. H., & Lee, B. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.07.007 · Cited by 114
Selective histone deacetylase small molecule inhibitors: recent progress and perspectives
Qin, H., Li, H., & Liu, F. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1276565 · Cited by 105
Small Molecule Inhibitors of Zinc-dependent Histone Deacetylases
Wagner, F. F., Weïwer, M., Lewis, M. C., & Holson, E. B. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0226-1 · Cited by 107
Thaler, F., & Mercurio, C. (2014) · ChemMedChem · doi:10.1002/cmdc.201300413 · Cited by 95
Discovery of the First Histone Deacetylase 6/8 Dual Inhibitors
Olson, D. E., Wagner, F. F., Kaya, T., Gale, J. P., Aidoud, N., Davoine, E. L., Lazzaro, F., Weïwer, M., Zhang, Y.-L., & Holson, E. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400390r · Cited by 90
Identification and characterization of nucleobase-modified aptamers by click-SELEX
Pfeiffer, F., Tölle, F., Rosenthal, M., Brändle, G. M., Ewers, J., & Mayer, G. (2018) · Nature Protocols · doi:10.1038/nprot.2018.023 · Cited by 102
Heimburg, T., Kolbinger, F. R., Zeyen, P., Ghazy, E., Herp, D., Schmidtkunz, K., Melesina, J., Shaik, T. B., Erdmann, F., Schmidt, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01447 · Cited by 92
An Unbiased Approach To Identify Endogenous Substrates of “Histone” Deacetylase 8
Olson, D. E., Udeshi, N. D., Wolfson, N. A., Pitcairn, C. A., Sullivan, E. D., Jaffe, J. D., Svinkina, T., Natoli, T., Lu, X., Paulk, J., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500492r · Cited by 81
Development of a Potent and Selective HDAC8 Inhibitor
Ingham, O. J., Paranal, R. M., Smith, W. B., Escobar, R. A., Yueh, H., Snyder, T., Porco, J. A., Bradner, J. E., & Beeler, A. B. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00239 · Cited by 77
Emerging approaches for histone deacetylase inhibitor drug discovery
Zwergel, C., Valente, S., Jacob, C., & Mai, A. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1038236 · Cited by 82
Fu, D., Li, P., Wu, B., Cui, X., Zhao, C., & Zhang, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.033 · Cited by 73
Suzuki, T., Muto, N., Bando, M., Itoh, Y., Masaki, A., Ri, M., Ota, Y., Nakagawa, H., Iida, S., Shirahige, K., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300414 · Cited by 71
Self-citationLi, J., Zhang, J., Rodrigues, M. C., Ding, D., Longo, J. P. F., Azevedo, R. B., Muehlmann, L. A., & Jiang, C. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.017 · Cited by 71
Han, S., Vogt, F., May, J. A., Krishnan, S., Gatti, M., Virgil, S. C., & Stoltz, B. M. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo502534g · Cited by 67
Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
Luo, Y., & Li, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228828 · Cited by 62
Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
Tang, G., Wong, J. C., Zhang, W., Wang, Z., Zhang, N., Peng, Z., Zhang, Z., Rong, Y., Li, S., Zhang, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008962 · Cited by 60
Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators
Zhan, P., Itoh, Y., Suzuki, T., & Liu, X. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00229 · Cited by 60
Self-citationSelective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC)
Chotitumnavee, J., Yamashita, Y., Takahashi, Y., Takada, Y., Iida, T., Oba, M., Itoh, Y., & Suzuki, T. (2022) · Chemical Communications · doi:10.1039/d2cc00272h · Cited by 59
Self-citationThe application of click chemistry in the synthesis of agents with anticancer activity
Sheng, J., Ma, N., Wang, Y., Ye, W., & Zhao, B. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s56038 · Cited by 65
Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors
Vreese, R. D., & D’hooghe, M. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.013 · Cited by 58
Tseng, H.-J., Lin, M.-H., Shiao, Y.-J., Yang, Y.-C., Chu, J.-C., Chen, C.-Y., Chen, Y.-Y., Lin, T. E., Su, C.-J., Pan, S.-L., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112193 · Cited by 53
Hényková, E., Vranová, H. P., Amakorová, P., Pospíšil, T., Žukauskaitė, A., Vlčková, M., Urbánek, L., Novák, O., Mareš, J., Kaňovský, P., et al. (2016) · Journal of Chromatography A · doi:10.1016/j.chroma.2016.02.009 · Cited by 54
Targeting of epigenetic regulators in neuroblastoma
Jubierre, L., Jiménez, C., Rovira, E., Soriano, A., Sábado, C., Gros, L., Llort, A., Hladun, R., Roma, J. M., de Toledo, J. S., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0077-2 · Cited by 69
Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
Xiao, W., Zhou, Q., Wen, X., Wang, R., Liu, R., Wang, T., Shi, J., Hu, Y., & Hou, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.702360 · Cited by 51
Nagesh, H. N., Naidu, K. M., Rao, D. H., Sridevi, J. P., Sriram, D., Yogeeswari, P., & Sekhar, K. V. G. C. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.016 · Cited by 53
Tilekar, K. N., Upadhyay, N., Jänsch, N., Schweipert, M., Mrówka, P., Meyer‐Almes, F., & Ramaa, C. S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103522 · Cited by 52
Debnath, S., Debnath, T., Bhaumik, S., Majumdar, S., Kalle, A. M., & Vema, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-53376-y · Cited by 52
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
Fontana, A., Cursaro, I., Carullo, G., Gemma, S., Butini, S., & Campiani, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710014 · Cited by 50
Darwish, S., Ghazy, E., Heimburg, T., Herp, D., Zeyen, P., Salem-Altintas, R., Ridinger, J., Schmidtkunz, K., Robaa, D., Erdmann, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147535 · Cited by 48
Click chemistry-aided drug discovery: A retrospective and prospective outlook
Zhao, R., Zhu, J., Jiang, X., & Bai, R. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116037 · Cited by 48
Small molecules as tools to study the chemical epigenetics of lysine acetylation
Schiedel, M., & Conway, S. J. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.06.015 · Cited by 42
Identification of novel SIRT2-selective inhibitors using a click chemistry approach
Tatum, P. R., Sawada, H., Ota, Y., Itoh, Y., Zhan, P., Ieda, N., Nakagawa, H., Miyata, N., & Suzuki, T. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.026 · Cited by 42
Self-citationKondo, Y., Iwao, T., Yoshihashi, S., Mimori, K., Ogihara, R., Nagata, K., Kurose, K., Saito, M., Niwa, T., Suzuki, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104010 · Cited by 43
Self-citationAmin, S. A., Adhikari, N., & Jha, T. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0130 · Cited by 45
Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors
Zhao, C., Zang, J., Ding, Q., Inks, E. S., Xu, W., Chou, C. J., & Zhang, Y. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.002 · Cited by 40
Methods for Hydroxamic Acid Synthesis
Alam, M. A. (2019) · Current Organic Chemistry · doi:10.2174/1385272823666190424142821 · Cited by 41
Kang, D., Feng, D., Jing, L., Sun, Y., Wei, F., Jiang, X., Wu, G., Clercq, E. D., Pannecouque, C. C., Zhan, P., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112237 · Cited by 38
ADrosophilaModel for Screening Antiobesity Agents
Mến, T. T., Thanh, D. N. V., Yamaguchi, M., Suzuki, T., Hattori, G., Arii, M., Huy, N. T., & Kamei, K. (2016) · BioMed Research International · doi:10.1155/2016/6293163 · Cited by 32
Self-citationXu, X. J., Kuang, Z., Han, J., Meng, Y., Li, L., Luan, H., Xu, P., Wang, J., Luo, C., Ding, H., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01035 · Cited by 38
Discovery of highly potent HDAC8 PROTACs with anti-tumor activity
Zhao, C., Chen, D., Suo, F., Setroikromo, R., Quax, W. J., & Dekker, F. J. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106546 · Cited by 41
Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD)
Bourguet, E., Ozdarska, K., Moroy, G., Jeanblanc, J., & Naassila, M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00115 · Cited by 36
Ghazy, E., Zeyen, P., Herp, D., Hügle, M. J., Schmidtkunz, K., Erdmann, F., Robaa, D., Schmidt, M., Ramos‐Morales, E., Romier, C., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112338 · Cited by 34
Cavasin, M. A., Stenmark, K. R., & McKinsey, T. A. (2015) · Pulmonary Circulation · doi:10.1086/679700 · Cited by 33
Overview of class I HDAC modulators: Inhibitors and degraders
Huang, Z., Zeng, L., Cheng, B., & Li, D. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116696 · Cited by 36
Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
Villalba, M., López-Royuela, N., Krzywińska, E., Rathore, M. G., Hipskind, R. A., Haouas, H., & Allende-Vega, N. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113136660374 · Cited by 34
Histone Deacetylase Inhibitors: Updated Studies in Various Epigenetic-Related Diseases
Zwergel, C., Stazi, G., Valente, S., & Mai, A. (2016) · Journal of Clinical Epigenetics · Cited by 43
Amin, S. A., Khatun, S., Gayen, S., Das, S., & Jha, T. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115594 · Cited by 34
Arunrungvichian, K., Fokin, V. V., Vajragupta, O., & Taylor, P. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00058 · Cited by 31
Liu, J., Zhu, Y., He, Y., Zhu, H., Gao, Y. Q., Li, Z., Zhu, J., Sun, X., Fang, F., Wen, H., et al. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1590241 · Cited by 30
Caselli, E., Romagnoli, C., Powers, R. A., Taracila, M. A., Bouza, A. A., Swanson, H. C., Smolen, K. A., Fini, F., Wallar, B. J., Bonomo, R. A., et al. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00153 · Cited by 30
HDAC8 regulates neural differentiation through embryoid body formation in P19 cells
Katayama, S., Morii, A., Makanga, J. O., Suzuki, T., Miyata, N., & Inazu, T. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.195 · Cited by 28
Self-citationStratton, M. S., & McKinsey, T. A. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0119 · Cited by 33
Tang, H., Liang, Y., Shen, H., Cai, S., Yu, M., Fan, H., Ding, K., & Wang, Y. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106112 · Cited by 27
Synthetic approach towards ‘click’ modified chalcone based organotriethoxysilanes; UV-Vis study
Singh, G., Singh, J., Mangat, S. S., & Arora, A. (2014) · RSC Advances · doi:10.1039/c4ra08724k · Cited by 26
Use of Click-Chemistry in the Development of Peptidomimetic Enzyme Inhibitors
Fabbrizzi, P., Menchi, G., Guarna, A., & Trabocchi, A. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131218093611 · Cited by 24
Advances of bioorthogonal coupling reactions in drug development
Zhan, F., Zhu, J., Xie, S., Xu, J., & Xu, S. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115338 · Cited by 24
Pyrrolopyrrole aza boron dipyrromethene based two-photon fluorescent probes for subcellular imaging
Zhou, Y., Ma, C., Gao, N., Wang, Q., Lo, P., Wong, K. S., Xu, Q., Kinoshita, T., & Ng, D. K. P. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01832d · Cited by 24
Itoh, Y., Zhan, P., Tojo, T., Jaikhan, P., Ota, Y., SUZUKI, M. T., Li, Y., Hui, Z., Moriyama, Y., Takada, Y., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01095 · Cited by 27
Self-citationNegmeldin, A. T., & Pflum, M. K. H. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.06.033 · Cited by 23
Yamada, M., Matsumura, M., Takino, F., Murata, Y., Kurata, Y., Kawahata, M., Yamaguchi, K., Kakusawa, N., & Yasuike, S. (2017) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201701389 · Cited by 23
Metalloprotein-Catalyzed Click Reaction for In Situ Generation of a Potent Inhibitor
Miyake, Y., Itoh, Y., Suzuma, Y., Kodama, H., Kurohara, T., Yamashita, Y., Narozny, R., Hanatani, Y., Uchida, S., & Suzuki, T. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c00369 · Cited by 23
Self-citationHDAC8 as a target in drug discovery: Function, structure and design
Zhao, Q., Liu, H., Peng, J., Niu, H., Liu, J., Xue, H., Liu, W., Liu, X., Hao, H., Zhang, X., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116972 · Cited by 25
Gorbunov, A. N., Kuznetsova, J., Владимирович, П. К., Kovalev, V. V., & Vatsouro, I. M. (2019) · New Journal of Chemistry · doi:10.1039/c8nj06464d · Cited by 22
The search for new amphiphiles: synthesis of a modular, high-throughput library
Feast, G. C., Lepitre, T., Mulet, X., Conn, C. E., Hutt, O. E., Savage, G. P., & Drummond, C. J. (2014) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.10.163 · Cited by 22
Zhao, C., Zhang, J., Zhou, H., Setroikromo, R., Poelarends, G. J., & Dekker, F. J. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00836 · Cited by 21
Kaleta, M., Hényková, E., Menšíková, K., Friedecký, D., Kvasnička, A., Klíčová, K., Koníčková, D., Strnad, M., Kaňovský, P., & Novák, O. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00611 · Cited by 22
Yamada, M., Matsumura, M., Sakaki, E., Yen, S.-Y., Kawahata, M., Hyodo, T., Yamaguchi, K., Murata, Y., & Yasuike, S. (2019) · Tetrahedron · doi:10.1016/j.tet.2019.01.056 · Cited by 20
Taleli, L., de Kock, C. A., Smith, P. J., Pelly, S. C., Blackie, M., & van Otterlo, W. A. L. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.06.044 · Cited by 20
Kashyap, K., & Kakkar, R. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1567388 · Cited by 20
Wakui, K., Abe, A., Yoshitomi, T., Furusho, H., & Yoshimoto, K. (2019) · Analytical Sciences · doi:10.2116/analsci.18sdn04 · Cited by 19
Okuda, Y., Imafuku, K., Tsuchida, Y., Seo, T., Akashi, H., & Orita, A. (2020) · Organic Letters · doi:10.1021/acs.orglett.0c01681 · Cited by 19
Lu, H., Wang, W., Li, X., Zhang, M., Cheng, X., Sun, K., Ding, Y., Li, X., & Hu, A. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00279a · Cited by 18
Gao, P., Zhang, L., Sun, L., Huang, T., Tan, J., Zhang, J., Zhou, Z., Zhao, T., Menéndez‐Arias, L., Pannecouque, C. C., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.09.006 · Cited by 17
Kashyap, K., & Kakkar, R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1711191 · Cited by 17
Hu, L., Liu, Y. A., & Liao, X. (2017) · Science Advances · doi:10.1126/sciadv.1700826 · Cited by 16
Castañeda, C. A., López, J. E., Joseph, C. G., Scholle, M. D., Mrksich, M., & Fierke, C. A. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00851 · Cited by 15
Kashyap, K., & Kakkar, R. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.103850 · Cited by 18
False HDAC Inhibition by Aurone Compound
Itoh, Y., SUZUKI, M. T., Matsui, T., Ota, Y., Hui, Z., Tsubaki, K., & Suzuki, T. (2016) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c16-00123 · Cited by 14
Self-citationQian, L., Zhang, C., Wu, J., & Yao, S. Q. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201603150 · Cited by 14
Ghazy, E., Heimburg, T., Lancelot, J., Zeyen, P., Schmidtkunz, K., Truhn, A., Darwish, S., Simoben, C. V., Shaik, T. B., Erdmann, F., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113745 · Cited by 14
Itoh, Y. (2019) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00741 · Cited by 15
Self-citation
Metadata
- Authors
- Suzuki, T., Ota, Y., Ri, M., Bando, M., Gotoh, A., Itoh, Y., Tsumoto, H., Tatum, P. R., Mizukami, T., Nakagawa, H., Iida, S., Ueda, R., Shirahige, K., & Miyata, N.
- Affiliations
- Kyoto Prefectural University of Medicine (JP)
- Nagoya City University (JP)
- The University of Tokyo (JP)
- Nagahama Institute of Bio-Science and Technology (JP)
- Corresponding author
- Suzuki, Takayoshi
- Miyata, Naoki
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-11-12
- Volume
- 55
- Issue
- 22
- Pages
- 9562-9575
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2029671140
- Cited by
- 165
- References
- 63
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 13 · 2023: 14 · 2022: 9 · 2021: 15 · 2020: 13 · 2019: 15 · 2018: 10 · 2017: 13 · 2016: 15 · 2015: 11 · 2014: 15 · 2013: 6
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (24659050, 24689007)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- HDAC8, HDAC8 inhibitors, selective inhibitors, click chemistry, triazole linkers, zinc-binding groups, hydrophobic pocket, T-cell lymphoma, neuroblastoma, anticancer agents
- MeSH terms
- Antineoplastic Agents, Histone Deacetylases, Humans, Models, Molecular, Neuroblastoma, Repressor Proteins, Tumor Cells, Cultured, Blotting, Western, Lymphoma, T-Cell, Apoptosis, Cell Proliferation, Small Molecule Libraries, Histone Deacetylase Inhibitors, Click Chemistry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.